Skip to main content
Patricia Coyle, MD, Neurology, East Setauket, NY

PatriciaKCoyleMD

Neurology • East Setauket, NY

Neuroimmunology/Multiple Sclerosis

Professor of Neurology, SUNY Stony Brook

Request Appointment

Overview of Dr. Coyle

I am an expert in Multiple Sclerosis and Neurologic Lyme Disease. I've been named as one of Castle Connolly Top Doctors® since 1999, most recently being named Top Doctors on New York Magazines 2021 list. I've held multiple leadership positions at the American Board of Psychiatry and Neurology, the American Academy of Neurology, the American Neurological Association, and the National MS Society. I've also served as an adviser to the Food and Drug Administration and the Institute of Medicine. I have received research funding from the NIH and the National MS Society, and am actively engaged in studies to understand and treat these diseases.

Education & Training

  • Johns Hopkins University
    Johns Hopkins UniversityFellowship, Neuroimmunology & Multiple Sclerosis, 1978 - 1980
  • Johns Hopkins University
    Johns Hopkins UniversityResidency, Neurology, 1975 - 1978
  • New York Presbyterian Hospital (Cornell Campus)
    New York Presbyterian Hospital (Cornell Campus)Internship, Internal Medicine, 1974 - 1975
  • Johns Hopkins University School of Medicine
    Johns Hopkins University School of MedicineClass of 1974

Certifications & Licensure

  • NY State Medical License
    NY State Medical License 1975 - 2026
  • MD State Medical License
    MD State Medical License 1978 - 1980
  • American Board of Psychiatry and Neurology Neurology

Awards, Honors, & Recognition

  • Invited Speaker Sanofi Genzyme, Real World Experience with Teriflunomide in Multiple Sclerosis Webinar, 2021
  • Invited Speaker Novartis, Jordan SPMS Advisory Board, 2021
  • Invited Speaker Sanofi Genzyme, KSA MS FORUM, 2021
  • Join now to see all

Publications & Presentations

PubMed

Journal Articles

  • Ofatumumab Versus Teriflunomide in Multiple Sclerosis  
    Stephen L Hauser, Amit Bar-Or, Patricia K Coyle, Alexandra Goodyear, The New England Journal of Medicine

Authored Content

  • Ofatumumab Versus Teriflunomide in Multiple SclerosisAugust 2020
  • Ofatumumab Versus Teriflunomide in Multiple SclerosisAugust 2020

Press Mentions

  • Prior Treatment Status: Impact on the Efficacy and Safety of Teriflunomide in Multiple Sclerosis
    Prior Treatment Status: Impact on the Efficacy and Safety of Teriflunomide in Multiple SclerosisOctober 6th, 2020
  • SPMS Triggers and Treatments Among Focus of Expert Panel in Video Series by AJMC
    SPMS Triggers and Treatments Among Focus of Expert Panel in Video Series by AJMCSeptember 10th, 2019
  • The American Journal of Managed Care®
    The American Journal of Managed Care®September 5th, 2019
  • Join now to see all

Professional Memberships

  • American Academy of Neurology - AAN
    Member
  • National Multiple Sclerosis Society
    Medical Board
  • Scientific Advisory Panel
    Member
  • Congressionally Directed Medical Research Programs (CDMRP)
    FDA CNS-PNS Advisory Panel
  • American Neurological Association (ANA)
    Member
  • NYSMSC Executive Committee
    Member

Insurance Accepted

  • Aetna Choice POS II
    Aetna HMO
    BCBS Blue Card PPO
    CIGNA HMO
    CIGNA Open Access
    CIGNA PPO
    Empire BCBS HMO
    Empire BCBS PPO
    GHI PPO
    Great West PPO
    Healthfirst New York
    HIP of New York - Select PPO
    Humana ChoiceCare Network PPO
    MagnaCare PPO
    Multiplan PHCS PPO
    Multiplan PPO
    MVP Healthcare PPO
    Oxford Health Freedom
    United Healthcare - Direct Choice Plus POS
    United Healthcare - Direct Options PPO
  • Please verify your coverage with the provider's office directly when scheduling an appointment

Dr. Patricia Coyle, Dr. Patricia Coyle, MD, Dr. P Coyle, Dr. Patricia K Coyle